Answers are grounded in this paper and cite their sources.
Since it is now well established that all patients with multiple myeloma have a preceding monoclonal gammopathy of undetermined significance (MGUS), identification of potential risk factors for the progression becomes most important. In this perspective article, Drs. Kyle and Kumar highlight the need for a better understanding of the etiology and biology of MGUS. See related paper on page 1714.
No takes yet. Share an insight, caveat, or question.
Kyle et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: